Mark Wedel, MD, JD
VP & CMO

Mark Wedel has several years of experience in the pharmaceutical industry. Before joining Santaris Pharma he worked as Senior Vice President of Drug Development and Chief Medical Officer responsible at Isis Pharmaceuticals where he was responsible for clinical operations, strategic therapeutic portfolio management, and overseeing Isis development programs including, cardiovascular, inflammatory, metabolic, infectious diseases, as well as oncology. Prior to Isis, Dr. Wedel held positions at Alliance Pharmaceutical Corp. as Director of Medical Affairs, Director of Pulmonary Therapeutics and consultant for the U.S. Department of Justice in its Health Care Fraud Division.

Dr. Wedel received his medical degree from The Johns Hopkins School of Medicine in Baltimore, Maryland and holds board certifications in Internal Medicine, Critical Care and Chest Medicine. He received a law degree from Thomas Jefferson School of Law, San Diego, California, and a B.A. from Valparaiso University, Valparaiso, Indiana. Dr. Wedel is the author of more than 35 professional publications, member of 12 professional societies, including the American Medical Association, American College of Physicians, Society of Critical Care Medicine, the American Thoracic Society, and the American Academy of Pharmaceutical Physicians.